Scivita Medical and the First Affiliated Hospital of Soochow University reached a cooperation intention for technical exchanges

Recently, a technical exchange meeting was held in the conference room of the park company Suzhou Scivita MedicalTechnology Co.. Ltd. Dean of the First Affiliated Hospital of Soochow University and a dozen directors and experts from various departments met with leaders and the elites of R&D and sales teams from Scivita Medical to discuss on cooperation project between hospital and industry.

Cooperation: why and how
Scivita Medical Technology Co.. Ltd. was developed on the basis of a high-tech medical device enterprise focusing on optical diagnosis and treatment, multi-dimensional imaging, high-performance materials and precision manufacturing. Over the past years, the company has not only maintained close cooperation with domestic experts, but also cooperated with related universities and companies in Europe, America and Japan.

Nowadays, they have high expectations for future development in Suzhou, hoping to research and develop more convenient minimally invasive medical equipment for clinicians. Zhang Yi, the Chairman of Scivita Medical, told reporters that they learnt a lot from the meeting. Later, they will visit various departments to collect feedback from doctors, which will help them to fine turn the product.

As a   "housekeeper"   serving the companies, the industrial park not only solved problems and difficulties they faced in its own development, but also managed to develop upstream and downstream industrial chains by breaking through the pain points and learning from lessons and experience, so that it supports companies located in the industrial park to advance vigorously and rapidly.

Hou Jianquan, Dean of the First Affiliated Hospital of Soochow University believes that how to establish a better interact between enterprises and hospitals deserves the efforts of both parts. For example, how to form an alliance that is attractive to well-known professionals is one of the topics 1 considered. In the meantime, they also look forward to working with government and enterprises to build a biomedical transformation platform thi first-class in China and of world-leading performance.
We are expecting to work closely together to bring more and better news to our patients.